SCHEMBL7553144

SCHEMBL7553144

COc1ccc(-c2cncc(-c3cn(CCN4CCCCC4)c4cc(Cl)ccc34)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.52
FLT1 P17948 3/20 0.47
FLT4 P35916 3/20 0.47
SIGMAR1 Q99720 1/20 0.40
CHRNB1 P11230 2/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
CHRNB3 Q05901 2/20 0.39
FLT3 P36888 1/20 0.39
ESR1 P03372 3/20 0.39
HRH3 Q9Y5N1 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
RCE1 Q9Y256 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
BCHE P06276 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549168 0.94 KDR (0.54) KDRFLT1FLT4SIGMAR1HRH3
SCHEMBL7554609 0.93 KDR (0.52) KDRFLT1FLT4SIGMAR1CHRNB1
SCHEMBL7988266 0.92 KDR (0.53) KDRFLT1FLT4FLT3ALDH1A1
SCHEMBL7552346 0.91 KDR (0.58) KDRFLT1FLT4SIGMAR1CHRNB1
SCHEMBL7551215 0.90 KDR (0.52) KDRFLT1FLT4FLT3ESR1
SCHEMBL7554276 0.89 KDR (0.52) KDRFLT1FLT4SIGMAR1CHRNB1
SCHEMBL7555221 0.87 KDR (0.68) KDRFLT1FLT4FLT3
SCHEMBL7555564 0.87 KDR (0.62) KDRFLT1FLT4FLT3
SCHEMBL7557189 0.87 KDR (0.54) KDRFLT1FLT4SIGMAR1ESR1
SCHEMBL7546871 0.87 KDR (0.56) KDRFLT1FLT4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed